Literature DB >> 8215618

Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.

P J Jongen1, G J Zoll, M Beaumont, W J Melchers, L B van de Putte, J M Galama.   

Abstract

OBJECTIVES: A persistent infection of enteroviruses and cardioviruses has been implicated in polymyositis and dermatomyositis, but conventional hybridisation studies of the presence of enterovirus RNA and encephalomyocarditis (EMC) virus RNA in affected muscle have yielded conflicting results. To investigate further the possibility of viral persistence, the presence of viral RNA in muscle from patients with adult onset polymyositis and dermatomyositis was investigated using a polymerase chain reaction (PCR) technique.
METHODS: Muscle tissue was obtained from 10 patients with polymyositis and five patients with dermatomyositis, all with adult onset active disease. A PCR was performed using primers with high specificity for enterovirus and EMC virus RNA, followed by Southern blot hybridisation with an oligonucleotide probe directed against the internal portion of the amplified product. A PCR directed against the Abelson tyrosine kinase mRNA served as an internal control for the presence and quality of RNA.
RESULTS: A specific amplification for enterovirus or for EMC virus could not be seen in any of the muscle biopsy samples, despite a sensitivity of about 30 plaque forming units for enterovirus and of 100 plaque forming units for EMC virus. Southern blot hybridisation confirmed these results in that positive controls hybridised with the oligonucleotide probe, but no signal was obtained with the muscle specimens.
CONCLUSION: A sensitive and specific PCR technique showed no evidence of the presence of enterovirus or EMC virus RNA in muscle samples from patients with polymyositis or dermatomyositis. These data do not support the proposal that viral RNA persistence plays a part in these idiopathic inflammatory myopathies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215618      PMCID: PMC1005113          DOI: 10.1136/ard.52.8.575

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Managing chronic hepatitis C virus infection.

Authors:  J Y Lau; G L Davis
Journal:  BMJ       Date:  1993-02-20

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease.

Authors:  R Kandolf; D Ameis; P Kirschner; A Canu; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

4.  Coxsackie B neutralisation titres in polymyositis/dermatomyositis.

Authors:  R L Travers; G R Hughes; G Cambridge; J R Sewell
Journal:  Lancet       Date:  1977-06-11       Impact factor: 79.321

5.  Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis.

Authors:  M L Christensen; L M Pachman; R Schneiderman; D C Patel; J M Friedman
Journal:  Arthritis Rheum       Date:  1986-11

6.  Evidence for a novel picornavirus in human dermatomyositis.

Authors:  N L Rosenberg; H A Rotbart; M J Abzug; S P Ringel; M J Levin
Journal:  Ann Neurol       Date:  1989-08       Impact factor: 10.422

7.  A murine model of polymyositis induced by coxsackievirus B1 (Tucson strain).

Authors:  S L Strongwater; K Dorovini-Zis; R D Ball; T J Schnitzer
Journal:  Arthritis Rheum       Date:  1984-04

8.  Dermatomyositis, polymyositis, and Coxsackie-B-virus infection.

Authors:  N E Bowles; V Dubowitz; C A Sewry; L C Archard
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

9.  Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues.

Authors:  M V Haspel; T Onodera; B S Prabhakar; M Horita; H Suzuki; A L Notkins
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

10.  The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral persistence demonstrated by in situ hybridization.

Authors:  M E Cronin; L A Love; F W Miller; P R McClintock; P H Plotz
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  4 in total

1.  Detection of enteroviruses and rhinoviruses in clinical specimens by PCR and liquid-phase hybridization.

Authors:  P Halonen; E Rocha; J Hierholzer; B Holloway; T Hyypiä; P Hurskainen; M Pallansch
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 2.  Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections.

Authors:  Sarah Jacob; Ronak Kapadia; Tyler Soule; Honglin Luo; Kerri L Schellenberg; Renée N Douville; Gerald Pfeffer
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

3.  Coxsackievirus B1-based antibody-capture enzyme-linked immunosorbent assay for detection of immunoglobulin G (IgG), IgM, and IgA with broad specificity for enteroviruses.

Authors:  C M Swanink; L Veenstra; Y A Poort; J A Kaan; J M Galama
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

4.  Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis.

Authors:  Monika Hofbauer; Solveigh Wiesener; Holger Babbe; Axel Roers; Hartmut Wekerle; Klaus Dornmair; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.